- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vor Biopharma Inc (VOR)
Vor Biopharma Inc stock price live, this page displays NASDAQ VOR stock exchange data. View the VOR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vor Biopharma Inc real time stock price chart below.
What Is the Vor Biopharma Inc Stock Price Today?
The Vor Biopharma Inc stock price today is 15.500.
What Is the Stock Symbol for Vor Biopharma Inc?
The stock ticker symbol for Vor Biopharma Inc is VOR.
Is VOR the Same as $VOR?
$VOR is a common way to refer to the Vor Biopharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vor Biopharma Inc Trade On?
Vor Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Vor Biopharma Inc a Good Stock to Buy?
Determining whether Vor Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vor Biopharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VOR quote. (ISIN: US9290332074)
What Is the Vor Biopharma Inc Stock Price Today?
The Vor Biopharma Inc stock price today is 15.500.
What Is the Stock Symbol for Vor Biopharma Inc?
The stock ticker symbol for Vor Biopharma Inc is VOR.
Is VOR the Same as $VOR?
$VOR is a common way to refer to the Vor Biopharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vor Biopharma Inc Trade On?
Vor Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Vor Biopharma Inc a Good Stock to Buy?
Determining whether Vor Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vor Biopharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VOR quote. (ISIN: US9290332074)
15.500
-0.370(-2.33%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.410
16.100
52 wk Range
2.622
65.800
VOR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.41016.100
52 wk Range
2.62265.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VOR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
37.625
Upside
+142.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Top insider buys and sells disclosed Friday
- Investing.com
- Top insider buys and sells disclosed Friday
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Vor Biopharma Inc SWOT Analysis
Future Prospects | Delve into Vor's assets, including intellectual property and manufacturing capabilities, that could prove valuable in potential strategic transactions |
Market Valuation Gap | Explore the intriguing disparity between Vor's stock price and its estimated pro forma cash value, presenting potential opportunities for investors |
Financial Health | With $92 million in cash but a weak financial health score, Vor faces a critical juncture as it navigates its strategic shift and preserves shareholder value |
Strategic Pivot | Vor Biopharma halts all development programs and explores strategic alternatives amid challenging market conditions and disappointing clinical results |
Compare VOR to Peers and Sector
Metrics to compare | VOR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVORPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −2.9x | −0.5x | |
PEG Ratio | 0.01 | −0.09 | 0.00 | |
Price / Book | −5.1x | 3.7x | 2.6x | |
Price / LTM Sales | - | 18.4x | 3.2x | |
Upside (Analyst Target) | 152.0% | 141.7% | 47.6% | |
Fair Value Upside | Unlock | 3.9% | 6.1% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 37.625
(+142.74% Upside)
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
84.89 / -0.09
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Vor Biopharma (VOR) Stock Price Today?
The Vor Biopharma stock price today is 15.500 USD.
What Stock Exchange Does Vor Biopharma Trade On?
Vor Biopharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Vor Biopharma?
The stock symbol for Vor Biopharma is "VOR."
What Is the Vor Biopharma Market Cap?
As of today, Vor Biopharma market cap is 837.710M USD.
What Is Vor Biopharma's Earnings Per Share (TTM)?
The Vor Biopharma EPS (TTM) is -70.502.
When Is the Next Vor Biopharma Earnings Date?
Vor Biopharma will release its next earnings report on Nov 07, 2025.
From a Technical Analysis Perspective, Is VOR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Vor Biopharma Stock Split?
Vor Biopharma has split 1 times.
How Many Employees Does Vor Biopharma Have?
Vor Biopharma has 76 employees.
What is the current trading status of Vor Biopharma (VOR)?
As of Apr 15, 2026, Vor Biopharma (VOR) is trading at a price of 15.500 USD, with a previous close of 15.870 USD. The stock has fluctuated within a day range of 15.410 USD to 16.100 USD, while its 52-week range spans from 2.622 USD to 65.800 USD.
What Is Vor Biopharma (VOR) Price Target According to Analysts?
The average 12-month price target for Vor Biopharma is 37.625 USD, with a high estimate of 50 USD and a low estimate of 15 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +142.74% Upside potential.
What Is the VOR Premarket Price?
VOR's last pre-market stock price is 16.100 USD. The pre-market share volume is 24,640.000, and the stock has decreased by 0.230, or 1.450%.
What Is the VOR After Hours Price?
VOR's last after hours stock price is 15.950 USD, the stock has decreased by 0.090, or 0.570%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.